Closely monitor blood pressure and heart rate frequently, especially during the initial conversion phase. Aim for at least daily monitoring for the first week, then adjust frequency based on individual patient response. Target heart rate should remain within the therapeutic range.
Monitoring Specifics
Assess for signs of bradycardia or hypotension. These include dizziness, lightheadedness, fainting, or shortness of breath. Document any changes meticulously. Consider continuous ECG monitoring in high-risk patients, such as those with pre-existing conduction disturbances or heart failure.
Regularly evaluate patient symptoms. Pay close attention to any worsening of angina, heart failure symptoms, or bronchospasm, particularly in patients with asthma or COPD. Adjust medication dosages as needed under the guidance of a physician, based on the individual’s response. Consider using a patient diary to track daily symptoms and medication usage.
Laboratory monitoring is generally not required unless clinically indicated. However, if you suspect significant electrolyte imbalances, renal issues, or other relevant factors, appropriate blood tests should be performed.
Maintain open communication with patients, actively addressing their concerns and providing education about the conversion process and potential side effects. Encourage prompt reporting of any unusual symptoms. Regular follow-up appointments, especially in the first few weeks, are paramount.
